X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1639) 1639
Publication (190) 190
Newspaper Article (133) 133
Newsletter (46) 46
Book Review (43) 43
Book Chapter (18) 18
Magazine Article (9) 9
Transcript (8) 8
Web Resource (7) 7
Government Document (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1108) 1108
humans (1061) 1061
immunotherapy (715) 715
maintenance (555) 555
female (527) 527
oncology (517) 517
male (441) 441
maintenance therapy (412) 412
cancer (366) 366
middle aged (336) 336
chemotherapy (332) 332
immunology (323) 323
adult (311) 311
aged (268) 268
animals (263) 263
treatment outcome (254) 254
hematology (237) 237
transplantation (237) 237
care and treatment (235) 235
therapy (212) 212
analysis (183) 183
patients (181) 181
research (175) 175
double-blind (163) 163
health aspects (163) 163
clinical trials (158) 158
tumors (150) 150
survival (148) 148
antineoplastic combined chemotherapy protocols - therapeutic use (143) 143
surgery (141) 141
rituximab (140) 140
health maintenance organizations (136) 136
antineoplastic agents - therapeutic use (131) 131
pharmacology & pharmacy (130) 130
open-label (127) 127
mice (124) 124
cancer therapies (122) 122
lymphocytes (119) 119
medicine & public health (119) 119
medical research (116) 116
risk factors (115) 115
adolescent (111) 111
drug therapy (110) 110
immunosuppressive agents - therapeutic use (108) 108
maintenance chemotherapy (106) 106
prognosis (106) 106
review (104) 104
antibodies, monoclonal - therapeutic use (103) 103
stem cells (103) 103
health maintenance organizations--hmos (101) 101
ovarian cancer (99) 99
trial (99) 99
aged, 80 and over (97) 97
t cells (96) 96
urology & nephrology (96) 96
article (95) 95
expression (95) 95
mutation (94) 94
induction (93) 93
young adult (90) 90
abridged index medicus (89) 89
immunosuppression (89) 89
lung cancer (89) 89
randomized-trial (89) 89
disease-free survival (87) 87
retrospective studies (87) 87
immunotherapy - methods (85) 85
medicine, research & experimental (83) 83
follow-up studies (82) 82
remission induction (82) 82
studies (80) 80
phase-ii trial (78) 78
usage (78) 78
child (77) 77
efficacy (77) 77
inflammatory bowel disease (77) 77
medicine, experimental (76) 76
recurrence (76) 76
kidneys (75) 75
risk (75) 75
time factors (75) 75
lymphomas (74) 74
medicine (74) 74
metastasis (74) 74
pharmaceutical industry (73) 73
cytokines (71) 71
follicular lymphoma (71) 71
immune system (71) 71
lymphocytes t (71) 71
phase-iii trial (71) 71
safety (71) 71
stem-cell transplantation (71) 71
allergy (70) 70
infliximab (69) 69
kidney transplantation (69) 69
monoclonal antibodies (69) 69
antigens (68) 68
inflammation (67) 67
proteins (65) 65
transplants & implants (65) 65
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1822) 1822
French (28) 28
German (4) 4
Japanese (3) 3
Spanish (2) 2
Chinese (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 02/2019, Volume 7, Issue 2, pp. 429 - 436.e2
Oral immunotherapy (OIT) for food allergy is demanding but data on patients' quality of life (QOL) throughout the process are limited. To characterize changes... 
Desensitization | Maintenance | Up-dosing phase | Oral immunotherapy | Quality of life | Follow-up | IMPACT | ALLERGY | IMMUNOLOGY | CHILDREN | PEANUT | Food allergies | Nuts | Asthma | Studies | Proteins | Immunotherapy | Questionnaires | Anxiety | Children | Food quality | Food hypersensitivity | Age
Journal Article
Scientific Reports, ISSN 2045-2322, 08/2016, Volume 6, Issue 1, p. 32020
Immunotherapy is a novel treatment for advanced non-small cell lung cancer (NSCLC) patients. Immunotherapy includes two main broad classes of therapeutic... 
CELL LUNG-CANCER | DENDRITIC CELLS | BELAGENPUMATUCEL-L | MULTIDISCIPLINARY SCIENCES | VACCINE | DOUBLE-BLIND | ORAL TALACTOFERRIN | PHASE-II | INDUCED KILLER-CELLS | MAINTENANCE THERAPY | CHEMOTHERAPY | Thrombocytopenia | Immune checkpoint | Cytokines | Immunomodulation | Immunotherapy | Clinical trials | Non-small cell lung carcinoma | Vaccines | Neutropenia
Journal Article
FRONTIERS IN MEDICINE, ISSN 2296-858X, 07/2019, Volume 6, p. 170
Background: Current Crohn's disease (CD) therapies focus on suppressing immune function and come with consequent risk, such as infection and cancer.... 
randomized placebo-controlled trial | microbial-based therapy | biomarkers | biologic | IMMUNE-DEFICIENCY | RECEPTOR | Crohn's disease | INDUCTION | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | innate immunity | COLITIS | IMMUNOSUPPRESSION | IL-18 | immunotherapy | ACTIVITY INDEX | T-CELLS | Immunotherapy
Journal Article
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, ISSN 2092-7355, 01/2020, Volume 12, Issue 1, pp. 99 - 109
Purpose: Allergen immunotherapy (AIT) induces immunological tolerance, and there is increasing evidence of the clinical efficacy of AIT in the treatment of... 
immunomodulation | DIAGNOSIS | MANAGEMENT | SAFETY | ADULTS | asthma | IMMUNOLOGY | desensitization | Allergens immunotherapy | ALLERGY | corticosteroid | adult | mite | Allergens | Parameters | Immunology | Weighting methods | Immunotherapy | Clinical trials | Maintenance | Immunological tolerance | Patients | Allergies | Asthma | 내과학
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 60, pp. 26 - 39
Abstract Small cell lung cancer (SCLC) is a smoking-induced malignancy with multiple toxin-associated mutations, which accounts for 15% of all lung cancers. It... 
Hematology, Oncology and Palliative Medicine | Targeted therapies | Cell signalling | Angiogenesis | Small cell lung cancer | Precision medicine | Immunotherapies | Molecular analysis | DNA repair | Apoptosis | Antibody-drug conjugate | COMPREHENSIVE GENOMIC ANALYSIS | INHIBITOR PANOBINOSTAT LBH589 | CARBOPLATIN | INDUCTION CHEMOTHERAPY | HOOSIER-ONCOLOGY-GROUP | PACLITAXEL PLUS BEVACIZUMAB | MAINTENANCE SUNITINIB | PHASE-II-TRIAL | ONCOLOGY | DOUBLE-BLIND | ENDOTHELIAL GROWTH-FACTOR | DNA Damage - drug effects | Cell Communication - immunology | DNA Repair - drug effects | Immunotherapy - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | DNA Damage - immunology | Lung Neoplasms - therapy | Drug Discovery | Apoptosis - immunology | Cell Cycle Checkpoints - drug effects | Immune System - drug effects | Cell Communication - drug effects | Angiogenesis Inhibitors - therapeutic use | DNA Repair - immunology | Small Cell Lung Carcinoma - therapy | Cell Cycle Checkpoints - immunology | Molecular Targeted Therapy - methods | Precision Medicine - methods | Viral antibodies | Chemotherapy | Biological products | Immunotherapy | Genomics | Antibodies | Lung cancer, Small cell | Drug therapy | Cancer | Medical research | DNA damage | Medicine, Experimental
Journal Article
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 06/2018, Volume 7, Issue 6, p. 151
Immune checkpoint inhibitors have shown efficacy in the treatment of non-small cell lung cancer (NSCLC) in the adjuvant, first- and subsequent-line settings.... 
non-small cell lung cancer | MULTICENTER | METAANALYSIS | SOLID TUMORS | VACCINE | OPEN-LABEL | DOCETAXEL | MAINTENANCE THERAPY | CHEMOTHERAPY | TRIAL | MEDICINE, GENERAL & INTERNAL | immunotherapy | NIVOLUMAB | checkpoint inhibitors
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 09/2017, Volume 13, Issue 9, pp. 2179 - 2184
Cancer Immunotherapetics differ fundamentally from most cancer therapies in that they involve manipulation of the immune system to induce an anti-tumor... 
trial design | systems immunology | translational immunology | PHASE-III | COMBINED NIVOLUMAB | IMMUNE-RELATED RESPONSE | OPEN-LABEL | IMMUNOLOGY | MAINTENANCE THERAPY | CHEMOTHERAPY | CELL LUNG-CANCER | ADVANCED MELANOMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DOUBLE-BLIND | IPILIMUMAB
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 7, pp. 7586 - 7596
Journal Article
OncoImmunology, ISSN 2162-4011, 01/2016, Volume 5, Issue 1, p. e1041701
Journal Article